Technical Analysis for CASI - CASI Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade C 3.2 0.95% 0.03
CASI closed up 0.95 percent on Friday, August 16, 2019, on 3.83 times normal volume. It was able to find support at its 50 day moving average. Its advance stalled at its 200 day moving average, an important long-term support / resistance line.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Up
See historical CASI trend table...

Date Alert Name Type % Chg
200 DMA Resistance Bearish 0.00%
20 DMA Support Bullish 0.00%
50 DMA Support Bullish 0.00%
New Uptrend Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Volume Surge Other 0.00%
Wide Range Bar Range Expansion 0.00%
Upper Bollinger Band Touch Strength 0.00%
Crossed Above 20 DMA Bullish 0.95%
Crossed Above 50 DMA Bullish 0.95%

Older signals for CASI ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
CASI Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops therapeutics to treat cancer and other diseases primarily in the United States and China. The company's lead drug candidate includes ENMD-2076, an Aurora A and angiogenic kinase inhibitor for the treatment of cancer, which has completed Phase I studies in patients with advanced solid tumors, multiple myeloma, and leukemia, as well as it is completing data for a multi-center Phase II study in patients with platinum resistant ovarian cancer. Its other product candidates in development include 2-methoxyestrdiol, an orally active compound for autoimmune diseases; and MKC-1, an orally-active cell cycle inhibitor that has completed Phase II clinical trials for cancer treatment. The company name was formerly known as EntreMed, Inc. and changed its name to CASI Pharmaceuticals, Inc. in June 2014. CASI Pharmaceuticals, Inc. was founded in 1991 and is headquartered in Rockville, Maryland.
Biotechnology Cancer Life Sciences Pharmaceutical Diseases Treatment Of Cancer Autoimmune Diseases Multiple Myeloma Cancer Treatment Leukemia Pyrrolidines Advanced Solid Tumors Cyclacel Pacritinib
Is CASI a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 8.2
52 Week Low 2.73
Average Volume 163,618
200-Day Moving Average 3.4203
50-Day Moving Average 3.1132
20-Day Moving Average 3.112
10-Day Moving Average 3.078
Average True Range 0.1649
ADX 26.08
+DI 30.3229
-DI 10.5439
Chandelier Exit (Long, 3 ATRs ) 3.0053
Chandelier Exit (Short, 3 ATRs ) 3.3947
Upper Bollinger Band 3.2375
Lower Bollinger Band 2.9865
Percent B (%b) 0.85
BandWidth 8.065553
MACD Line -0.0014
MACD Signal Line -0.0123
MACD Histogram 0.0109
Fundamentals Value
Market Cap 192.63 Million
Num Shares 60.2 Million
EPS -0.13
Price-to-Earnings (P/E) Ratio -24.62
Price-to-Sales 0.00
Price-to-Book 7.28
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.82
Resistance 3 (R3) 3.85 3.67 3.71
Resistance 2 (R2) 3.67 3.52 3.66 3.68
Resistance 1 (R1) 3.44 3.42 3.35 3.41 3.64
Pivot Point 3.26 3.26 3.22 3.25 3.26
Support 1 (S1) 3.03 3.11 2.94 3.00 2.76
Support 2 (S2) 2.85 3.01 2.84 2.72
Support 3 (S3) 2.62 2.85 2.69
Support 4 (S4) 2.59